Logo image
Sign in
QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX
Journal article   Peer reviewed

QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX

B Monk, H Huang, D Cella and H Long
International journal of gynecological cancer, Vol.14(Suppl 1), pp.42-42
09/01/2004

Metrics

1 Record Views

Details